Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
US Army
Merck
Moodys
Farmers Insurance
Queensland Health
Teva
Argus Health
Cerilliant

Generated: April 24, 2018

DrugPatentWatch Database Preview

ZELNORM Drug Profile

« Back to Dashboard

When do Zelnorm patents expire, and when can generic versions of Zelnorm launch?

Zelnorm is a drug marketed by Us Worldmeds Llc and is included in one NDA.

The generic ingredient in ZELNORM is tegaserod maleate. Additional details are available on the tegaserod maleate profile page.
Summary for ZELNORM
Drug patent expirations by year for ZELNORM
Synonyms for ZELNORM
(2E)-2-[(5-methoxy-1H-indol-3-yl)methylene]-N-pentylhydrazinecarboximidamide
(Z)-2-butenedioic acid;1-[[(Z)-(5-methoxy-3-indolylidene)methyl]amino]-2-pentylguanidine
(Z)-but-2-enedioic acid; 1-[[(Z)-(5-methoxyindol-3-ylidene)methyl]amino]-2-pentylguanidine
(Z)-but-2-enedioic acid;1-[[(Z)-(5-methoxyindol-3-ylidene)methyl]amino]-2-pentyl-guanidine
(Z)-but-2-enedioic acid;1-[[(Z)-(5-methoxyindol-3-ylidene)methyl]amino]-2-pentylguanidine
1-(((5-Methoxyindol-3-yl)methylene)amino)-3-pentylguanidine
1-[[(Z)-(5-methoxyindol-3-ylidene)methyl]amino]-2-pentyl-guanidine
1-[[(Z)-(5-methoxyindol-3-ylidene)methyl]amino]-2-pentylguanidine
1184963-48-1
145158-71-0
188T576
189188-57-6
189188-57-6 (maleate)
2-((5-Methoxy-1H-indol-3-yl)methylene)-N-pentylhydrazinecarboximidamide
2-[(5-Methoxy-1H-indol-3-yl)methylene]-N-pentyl-hydrazinecarboximidamide maleate
2-[(5-Methoxy-1H-indol-3-yl)methylene]-N-pentylhydrazinecarboximidamide (2Z)-2-Butenedioate
2-[(5-methoxy-1H-indol-3-yl)methylene]-N-pentylhydrazinecarboximidamide (2Z)-but-2-enedioic acid
2-[(5-methoxy-1h-indol-3-yl)methylene]-n-pentylhydrazinecarboximidamide, maleate
2-[(5-Methoxy-1H-indole-3-yl)methylene]-N-pentylcarbazimidamide hydrogen maleate
2-[(5-methoxy-2,3-dihydro-1H-indol-3-yl)methylene]-N-pentylhydrazinecarboximidamide
2-amyl-1-[[(Z)-(5-methoxyindol-3-ylidene)methyl]amino]guanidine;maleic acid
3-(5-methoxy-1h-indol-3-ylmethylene)-N-pentyl-carbazimidamide
3-(5-Methoxy-1H-indol-3-ylmethylene)-N-pentylcarbazimidamide hydrogen maleate
458VC51857
58T710
AB01209613-01
AB01209613-03
AB01563050_01
AB2000472
AC-4564
AC1NSFYX
AC1OCFCM
AK129843
AK175419
AKOS015894930
AKOS015913793
AKOS024458253
AM84414
Ambap145158-71-0
AN-11838
AN-15007
AS-13059
AT-3939
B7690
BC206423
BC208394
BDBM50240618
BDBM79022
BSPBio_002344
BSPBio_003270
C16H23ON5.C4H4O4
CAS-145158-71-0
CCG-101019
CCG-221214
CCG-40062
CHEBI:51043
CHEBI:51044
CHEBI:94540
CHEMBL1516474
CHEMBL76370
cid_6918369
CPD000471618
CS-4234
CT0137
D00XWD
D01AUI
D02730
D06056
DB01079
DSSTox_CID_25955
DSSTox_GSID_45955
DSSTox_RID_81251
DTXSID6045955
GTPL226
H172
HMS1922J08
HMS1922N11
HMS2051J10
HMS2231G21
HTF 919
HTF-919
HY-14153A
HYD017
Hydrazinecarboximidamide, 2-((5-methoxy-1H-indol-3-yl)methylene)-N-pentyl-
Hydrazinecarboximidamide, 2-[(5-methoxy-1H-indol-3-yl)methylene]-N-pentyl-
I06-0055
I06-055
I14-44719
J-008063
J-012203
KB-80828
KBio2_002496
KBio2_005064
KBio2_007632
KBio3_002771
KBioGR_001000
KBioSS_002504
LP074773
maleic acid; 1-[[(Z)-(5-methoxyindol-3-ylidene)methyl]amino]-2-pentyl-guanidine
MLS001401406
MolPort-003-666-612
MolPort-009-194-204
MolPort-023-220-263
N-({[(3Z)-5-METHOXYINDOL-3-YLIDENE]METHYL}AMINO)-N''-PENTYLGUANIDINE
NC00269
NCGC00095144-01
NCGC00095144-02
NCGC00095192-01
NCGC00095192-02
NCGC00095192-03
NCGC00095192-04
NCGC00095192-05
NSC-760425
NSC760425
Pharmakon1600-01505215
REGID_for_CID_6918369
SAM001246606
SCHEMBL1042179
SCHEMBL16464
SCHEMBL27215
SCHEMBL3893820
SCHEMBL774763
SCHEMBL8194377
SCHEMBL8229619
SDZ-HTF 919
SDZ-HTF-919
SF303
SMR000471618
SPBio_001180
Spectrum_001950
SPECTRUM1505215
SPECTRUM1505823
Spectrum2_001100
Spectrum3_001855
Spectrum4_000730
Spectrum5_001691
SR-01000763155
SR-01000763155-3
SR-05000001865
SR-05000001865-2
ST51052684
Tegaserod
Tegaserod (maleate)
Tegaserod (USAN/INN)
Tegaserod Hydrogen Maleate
Tegaserod maleate
Tegaserod maleate (USAN)
Tegaserod maleate, >=98% (HPLC)
Tegaserod, Maleate
tegaserodmalate
tegaserodum
tegastrodmaleate
Tegibs 6
TL8001540
Tox21_111481
Tox21_111481_1
UNII-458VC51857
Zelmac
Zelnorm (TN)
ZINC96125875

US Patents and Regulatory Information for ZELNORM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Us Worldmeds Llc ZELNORM tegaserod maleate TABLET;ORAL 021200-001 Jul 24, 2002 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Us Worldmeds Llc ZELNORM tegaserod maleate TABLET;ORAL 021200-002 Jul 24, 2002 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
McKinsey
Medtronic
US Army
Express Scripts
Cipla
Fish and Richardson
Federal Trade Commission
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.